hydrocortisone acetate has been researched along with Tuberculosis, Pulmonary in 2 studies
hydrocortisone acetate: RN given refers to cpd without isomeric designation
Tuberculosis, Pulmonary: MYCOBACTERIUM infections of the lung.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y | 1 |
| Liu, A | 1 |
| Menendez, MC | 1 |
| Garcia, MJ | 1 |
| Oravcova, K | 1 |
| Gillespie, SH | 1 |
| Davies, GR | 1 |
| Mitchison, DA | 1 |
| Coates, AR | 1 |
| TREGNAGHI, G | 1 |
| BAZZERLA, M | 1 |
2 other studies available for hydrocortisone acetate and Tuberculosis, Pulmonary
| Article | Year |
|---|---|
HspX knock-out in Mycobacterium tuberculosis leads to shorter antibiotic treatment and lower relapse rate in a mouse model--a potential novel therapeutic target.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antigens, Bacterial; Bacterial Proteins; C | 2015 |
[Hydrocortisone acetate in therapy of tuberculous exudative pleurisy].
Topics: Humans; Hydrocortisone; Pleurisy; Tuberculosis; Tuberculosis, Pulmonary | 1958 |